Shares of Lantheus Holdings Inc. (NASDAQ:LNTH) dropped 4.7% during trading on Monday . The stock traded as low as $3.95 and last traded at $4.05, with a volume of 60,657 shares changing hands. The stock had previously closed at $4.25.

LNTH has been the topic of a number of research analyst reports. Zacks Investment Research cut Lantheus Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, April 5th. Robert W. Baird restated a “hold” rating on shares of Lantheus Holdings in a report on Monday, April 11th. Finally, Jefferies Group restated a “buy” rating on shares of Lantheus Holdings in a report on Wednesday, May 4th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Lantheus Holdings presently has a consensus rating of “Hold” and an average price target of $5.65.

The stock’s market cap is $118.13 million. The stock has a 50-day moving average price of $3.89 and a 200 day moving average price of $2.56.

Lantheus Holdings (NASDAQ:LNTH) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported $0.34 EPS for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.28. The company earned $76.50 million during the quarter, compared to analysts’ expectations of $72.43 million. On average, equities analysts predict that Lantheus Holdings Inc. will post $0.35 earnings per share for the current year.

Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.